antidiabetic agent

antidiabetic agent

Any agent intentionally used to improve glucose control (e.g., efficiency of glucose utilisation).
 
Types
▪ Parenteral (e.g., insulin, exenatide, liraglutide and pramlintide).
▪ Oral hypoglycaemic agents.
References in periodicals archive ?
Efficacy of bromocriptine mesylate as add-on oral antidiabetic agent in type 2 diabetes mellitus.
An antidiabetic agent that is weight-neutral or that promotes weight loss, such as an SGLT2 inhibitor or a GLP-1 agonist, would be more suitable.
Metformin is a biguanide oral antidiabetic agent which is commonly used in the treatment of diabetes mellitus.
HONG KONG, Nov 24, 2015 - (ACN Newswire) - Uni-Bio Science Group Limited ("Uni-Bio" or the "Group"; HKEx code: 690) today announced that it will acquire exclusive global rights to manufacture and commercialise mitiglinide, a new oral antidiabetic agent, from Jiangsu Hansoh Pharmaceutical Co.
2010) Metformin is currently used as antidiabetic agent in the treatment of type 2 diabetes.
Nearly all elderly patients with type 2 diabetes will be started on some antidiabetic agent at some point, Dr.
4 Treatment with a single antidiabetic agent is often unsuccessful in achieving and /or maintaining glycemic control in patients with type 2 DM and many patients require combination of antidiabetic agents.
Still, the findings present the immediate opportunity to explore NuSE as an antidiabetic agent.
They recommended use of Aloe vera as an antidiabetic agent (25,26,27).
The PROactive Study (Prospective Pioglitazone Clinical Trial In Macrovascular Events Study) showed that ACTOS (generic name: pioglitazone HCI), an oral antidiabetic agent, can reduce the risk of developing and dying of cardiovascular diseases including heart attack and strokes in type 2 diabetics.
For example, patients with newly diagnosed, but untreated, diabetes, with no evidence of end organ damage, would be used to test a new antidiabetic agent.
5% and [less than or equal to] 10% who failed to achieve glycemic control with two oral antidiabetic drugs for [greater than or equal to] 3 months; hence a third antidiabetic agent was desirable in our patients.